PF-AtlasClinical Trials › NCT06296394

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

Parenthood · Not specified

Registry ID
NCT06296394
Phase
Not specified
Status
Recruiting
Drug / intervention
Parenthood
Sponsor
University of Pittsburgh
Start
2024-05-29
Enrollment
146
Locations
18

About this trial

The goal of this observational prospective study is to determine the health impact of parenthood on United States (US) people with CF in the era of CF transmembrane regulator protein (CFTR) modulators. The investigators will collect physical and mental health data to comprehensively evaluate the impact of parenthood in CF with widespread highly effective CFTR modulator use. The main hypotheses this study aims to examine are: H1: Parents with CF and moderate-to-severe depression have more rapid change in ppFEV1 (percent predicted forced expiratory volume in one second) versus those with mild or no depression. H2: Parents with CF who have more parental responsibility and/or stress have more rapid ppFEV1 (percent predicted forced expiratory volume in one second) change than those with less responsibility/stress H3: Parents using CFTR modulators have decreased ppFEV1 (percent predicted forced expiratory volume in one second) change versus those not using CFTR modulators Participants will complete quarterly surveys during the first year of parenthood and biannual surveys, thereafter, using the computer-based survey system on an iPad protected for infection control or via personal device or computer via emailed survey link.

View NCT06296394 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT06296394 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.